Correction to: Sars-Cov-2 Infection in People with Type 1 Diabetes and Hospital Admission: An Analysis of Risk Factors for England

Diabetes Ther. 2023 Dec;14(12):2043-2044. doi: 10.1007/s13300-023-01483-5.

Adrian H Heald^{1

2}, David A Jenkins^{3

4}, Richard Williams^{3

4

5}, Rajshekhar N Mudaliar⁶, Amber Khan⁶, Akheel Syed^{7

6}, Naveed Sattar⁸, Kamlesh Khunti⁹, Asma Naseem⁶, Kelly A Bowden-Davies¹⁰, J Martin Gibson^{7

6}, William Ollier¹¹; CVD-COVID-UK/COVID-IMPACT Consortium

¹ The School of Medicine-Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, UK. adrian.heald@manchester.ac.uk.
² Department of Diabetes and Endocrinology, Salford Royal NHS Foundation Trust, Salford, UK. adrian.heald@manchester.ac.uk.
³ Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
⁴ NIHR Greater Manchester Patient Safety Translational Research Centre, The University of Manchester, Manchester, UK.
⁵ NIHR Applied Research Collaboration Greater Manchester, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
⁶ Department of Diabetes and Endocrinology, Salford Royal NHS Foundation Trust, Salford, UK.
⁷ The School of Medicine-Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, UK.
⁸ School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
⁹ Diabetes Research Centre, University of Leicester, Leicester, UK.
¹⁰ Department of Sport and Exercise Sciences, Musculoskeletal Science and Sports Medicine Research Centre, Manchester Metropolitan University, Manchester, UK.
¹¹ Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, UK.

No abstract available

Publication types